Short answer · Medically reviewed summary · Last updated: 2026-04-06
The prevalence of Sjögren’s syndrome is estimated to be between 0.01% and 0.1% of the general population globally, though these figures vary significantly depending on the diagnostic criteria used and geographical region. Epidemiological Overview Estimating the exact number of people living with Sjögren is challenging because the condition is frequently underdiagnosed or misdiagnosed as other autoimmune disorders. While some studies suggest a global prevalence closer to 0.5% when including milder or subclinical cases, it is generally classified as a rare disease.
What is the prevalence of Sjogren?
Prevalence of Sjogren: how many people are affected worldwide, differences by sex and region, with sources.
The prevalence of Sjögren’s syndrome is estimated to be between 0.01% and 0.1% of the general population globally, though these figures vary significantly depending on the diagnostic criteria used and geographical region.
Epidemiological Overview
Estimating the exact number of people living with Sjögren is challenging because the condition is frequently underdiagnosed or misdiagnosed as other autoimmune disorders. While some studies suggest a global prevalence closer to 0.5% when including milder or subclinical cases, it is generally classified as a rare disease. Incidence rates are equally difficult to pinpoint, though some clinical literature suggests an incidence of approximately 3 to 6 per 100,000 person-years.
Demographics and Onset
Sjögren exhibits a striking gender disparity, with approximately 9 out of 10 diagnosed individuals being female. While the disease can manifest at any age, including in pediatric populations, the typical age of onset for Sjögren is between 40 and 60 years. There is no definitive evidence of significant ethnic predisposition, although variations in healthcare access and diagnostic awareness often skew reported data across different regions.
Challenges in Data Collection
The primary barrier to accurate prevalence data is the wide spectrum of symptoms—ranging from mild dry eyes to severe systemic vasculitis or neuropathy—which often leads patients to seek care from various specialists before receiving a formal diagnosis. At DiseaseMaps.org, we have seen over 730 individuals join our community, highlighting the importance of patient-reported data in capturing the real-world burden of Sjögren that traditional clinical registries may miss. This community data serves as a vital complement to existing epidemiological studies, helping us better understand the lived experience of those navigating the complexities of this condition.
Medical Disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of your rheumatologist or other qualified health provider with any questions regarding your medical condition.
References
- Orphanet: Rare Disease Database (Sjögren syndrome)
- NIH Genetic and Rare Diseases Information Center (GARD)
- Sjögren’s Foundation: Research and Prevalence Data
